Guidant To Retrain Staff In Response To FDA Inspection

Guidant will retrain internal quality systems auditors at all of its cardiac rhythm management device manufacturing sites, including in Puerto Rico and Ireland, the company says in its response to a Form 483 issued by FDA last month

More from Archive

More from Medtech Insight